Erik Pendleton
AeroLeads people directory · profile

Erik Pendleton Email & Phone Number

Scientist at Vividion Therapeutics
Location: San Diego, California, United States 8 work roles 2 schools
1 work email found @vividion.com 4 phones found area 908, 858, and 703 LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 86%

Contact Signals · 1 work email · 4 phones

Work email e****@vividion.com
Direct phone (908) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Role
Scientist at Vividion Therapeutics
Location
San Diego, California, United States

Who is Erik Pendleton? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Erik Pendleton is listed as Scientist at Vividion Therapeutics based in San Diego, California, United States. AeroLeads shows a work email signal at vividion.com, phone signal with area code 908, 858, 703, and a matched LinkedIn profile for Erik Pendleton.

Erik Pendleton previously worked as Associate Scientist at Vividion Therapeutics and Sr. Research Associate at Kyowa Kirin Pharmaceutical Research, Inc.. Erik Pendleton holds Master Of Science (M.S.), Biological Sciences, 3.59 from University Of California, Irvine.

Company email context

Email format at vividion.com

This section adds company-level context without repeating Erik Pendleton's masked contact details.

*@vividion.com
68% confidence

AeroLeads found 1 current-domain work email signal for Erik Pendleton. Compare company email patterns before reaching out.

Profile bio

About Erik Pendleton

I enjoy finding ways to accomplish complex research objectives by learning new methodologies while drawing upon my diverse 15 years of biotech experience.I am currently with Kyowa Kirin Pharmaceutical Research developing antisense therapeutics targeting autoimmune diseases. Previously I was at Celgene leading cellular mechanism-of-action studies for a small-molecule program targeting cancer metabolism. I developed and validated high-content imaging assays to determine cytological effects of inhibitors of stress metabolism pathways, and generated proof-of-concept studies demonstrating sensitivity of leukemia cells to pharmacological alterations of epigenetic and metabolic pathways.For 6 years I worked on advanced biotechnology R&D projects at Leidos Corp (formerly SAIC), translating cutting edge science into useful solutions. I helped find wound-specific binding sites (patented) and fabricated wound-binding microspheres for delivering a hemostatic agent (published 2016). I helped develop a way to detect foreign genetic modifications in organisms, without prior knowledge of what these modifications are (published 2015). I cloned, expressed and characterized membrane receptors used as biosensors for detecting explosive-making materials and most recently, worked on the development of a portable system capable of rapidly manufacturing therapeutic proteins in the field (published 2015, patent pending). Before joining SAIC/Leidos, I worked at Sangart, where I used sophisticated in vivo techniques to investigate physiological effects of artificial blood on transgenic mice expressing the human sickle cell mutation.I earned my Master’s Degree investigating neuronal growth and regeneration at the University of California - Irvine and graduated Cum Laude with a Bachelor of Science degree in Chemistry from San Diego State University. I currently have a security clearance.

Listed skills include Problem Solving, Analysis, Molecular Biology, Recombinant Dna, and 31 others.

8 roles

Erik Pendleton work experience

A career timeline built from the work history available for this profile.

Sr. Research Associate

Kyowa Kirin Pharmaceutical Research, Inc.

San Diego, Ca

Aug 2016 - Apr 2017

Research Associate

San Diego, Ca

Investigated biological effects of small-molecule inhibitors of the MAPK/ERK pathway. Developed Gene Expression profiling in support of translational efforts. Investigated lysosomal drug sequestation.

Feb 2016 - Jun 2016

Research Associate

Leading cellular mechanism-of-action studies for a small-molecule program targeting cancer metabolism. Developed and validated high-content imaging assays to determine cytological effects of inhibitors of stress metabolism pathways. Generating proof-of-concept studies demonstrating sensitivity of leukemia cells to pharmacological alterations of epigenetic and metabolic pathways.Managing compound progression and reporting to project team.

Jun 2015 - Dec 2015

Life Scientist Iii

Greater San Diego Area

Working on advanced biotechnology R&D projects. • Worked on development of a portable system capable of manufacturing therapeutic proteins in the field (patent pending): Sullivan, C.J., Pendleton, E.D., Sasmor, H.H., Hicks, W.L., Farnum, J.B., Muto, M., Amendt, E.M., Schoborg, J.A., Martin, R.W., Clark, L.G., Anderson, M.J., Choudhury, A., Fior, R., Lo,Y.H.,Griffey, R.H., Chappell, S.A., Jewett, M.C., Mauro, V.P., and Dresios, J. 2015. A cell-free expression and purification process for rapid production of protein biologics. Submitted.- Developed novel cell-free protein expression systems for expression of therapeutic proteins- Methods optimization for protein purification from complex cellular mixtures- Analyzed biological activity of manufactured proteins• Developed novel method of identifying genetically modified organisms (GMOs):Challise J.Sullivan 1, Erik D.Pendleton 1, Rachel E.Abrams 1, David L.Valente, Michelle L.Alvarez, Richard H.Griffey, John Dresios "Chromatin structure analysis enables detection of DNAinsertions into the mammalian nuclear genome' Biochemistry and Biophysics Reports 2(2015)143–152- Researched, set up and performed ChIP-sequencing to characterize epigenetic signatures of GMOs- Designed probes for interrogating methylation changes in GMOs• Developed system to stop bleeding of internal wounds (patent #8,663,932)- Identified wound-specific markers- Designed and fabricated wound-binding microspheres; demonstrated specific microparticle binding to injured sites in animal models of lethal injury• Developed biosensors capable of detecting explosive materials- Protein engineered >100 GPCRs (membrane odor receptors)- Developed in vitro system to express membrane receptor proteins- Developed assays to detect bioactivity of odor receptors in vitro

Aug 2009 - Mar 2015

Research Associate

Sangart

Greater San Diego Area

Investigated pharmacodynamic/pharmacokinetic properties of Hemoglobin Based Oxygen Carriers (HBOCs)• Developed in vivo models to investigate physiological effects of HBOCs on transgenic mice expressing the human sickle cell mutation.- Anesthetized mice, set up mechanical ventilation, monitored blood gas and blood pressure.- Induced sickle state and monitored blood flow changes with a laser doppler. • Investigated pharmacokinetics of HBOCs in a rat model.- Helped develop ELISA assay used to quantify Polyethylene Glycol (PEG) and PEG-coated molecules at nanomolar levels in tissue and serum.- Surgically installed cannulas in rats, administered HBOCs and monitored drug metabolism.

Jan 2007 - Jun 2009

Research Associate

Immusol, Inc. (Currently Itherix)

Greater San Diego Area

- Helped improve in vitro oncogene discovery system using ribozyme/siRNA libraries to screen human cell lines for genes involved with ligand induced apoptosis. - Created stable and transiently transfected cell lines- Performed sub-cloning/plasmid construction. - Optimized ribozyme/siRNA library extraction from transduced cell cultures. - Utilized TUNEL assays/FACS to isolate apoptotic cells.

Jan 2001 - Jul 2003

Research Assistant

Gen-Probe

Greater San Diego Area

Tested sensitive HIV-1/HCV blood screening assay for FDA approval

Jan 2000 - Dec 2000
2 education records

Erik Pendleton education

Master Of Science (M.S.), Biological Sciences, 3.59

Activities and Societies: Taught laboratory courses as a Teacher's Assistant - Investigated mechanisms controlling neuronal growth.

FAQ

Frequently asked questions about Erik Pendleton

Quick answers generated from the profile data available on this page.

What is Erik Pendleton's role at their current company?

Erik Pendleton is listed as Scientist at Vividion Therapeutics.

What is Erik Pendleton's email address?

AeroLeads has found 1 work email signal at @vividion.com for Erik Pendleton.

What is Erik Pendleton's phone number?

AeroLeads has found 4 phone signal(s) with area code 908, 858, 703 for Erik Pendleton.

Where is Erik Pendleton based?

Erik Pendleton is based in San Diego, California, United States.

What companies has Erik Pendleton worked for?

Erik Pendleton has worked for Vividion Therapeutics, Kyowa Kirin Pharmaceutical Research, Inc., Wellspring Biosciences, Celgene, and Leidos Corp. (Formerly Saic).

How can I contact Erik Pendleton?

You can use AeroLeads to view verified contact signals for Erik Pendleton, including work email, phone, and LinkedIn data when available.

What schools did Erik Pendleton attend?

Erik Pendleton holds Master Of Science (M.S.), Biological Sciences, 3.59 from University Of California, Irvine.

What skills is Erik Pendleton known for?

Erik Pendleton is listed with skills including Problem Solving, Analysis, Molecular Biology, Recombinant Dna, Animal Surgery, Animal Models, Primary Cell Isolation, and Protein Purification.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the Erik Pendleton you were looking for.

View similar profiles